The global investigational new drug CDMO market size was estimated at USD 5.21 billion in 2024 and is projected to reach USD 10.40 billion by 2033, growing at a CAGR of 8.66% from 2025 to 2033. The market growth is primarily driven by the rising outsourcing demand from pharmaceutical and biotechnology companies, the increasing complexity of drug development pipelines, and a growing...